By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

Andre Esteva, PhD, is an AI scientist, entrepreneur, and CEO of ArteraAI, revolutionizing cancer therapy through personalized diagnostics. A globally recognized ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...

After stomach cancer is diagnosed, a team of cancer specialists will work together with you to develop a personalized ...

Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be continued and why. A new study published in JAMA Oncology from ...

Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...